Oxybutynin as an alternative treatment for hyperhidrosis

Area of Science:

• Dermatology and Pharmacology

Background:

• Hyperhidrosis involves excessive sweating, categorized as primary focal or secondary to other conditions.
• Primary focal hyperhidrosis has an unknown cause but a recognized genetic link, affecting 1-2.8% of the population.
• Commonly affected areas include the armpits, palms, soles, and face, significantly impacting quality of life.

Purpose of the Study:

• To review the efficacy and application of oxybutynin for treating hyperhidrosis.
• To evaluate oxybutynin, an anticholinergic medication, as a therapeutic option for excessive sweating.

Main Methods:

• Literature review of studies on hyperhidrosis treatments.
• Focus on clinical data and research concerning oxybutynin's use in managing hyperhidrosis.

Main Results:

• Oxybutynin, typically used for overactive bladder, is investigated for its potential in reducing excessive sweating.
• The review synthesizes current understanding of oxybutynin's effectiveness in hyperhidrosis management.

Conclusions:

• Oxybutynin presents a potential treatment avenue for hyperhidrosis, warranting further clinical investigation.
• The review highlights the need for greater recognition and effective management strategies for hyperhidrosis.